Huhtamaki India is trading at attractive valuation and can be bought for 56% upside potential: SMIFS
The company is intentionally avoiding low-margin business opportunities even if that means growing slower...
Ackman’s strategy reflects a classic long-term investing philosophy: buy extraordinary businesses during periods of...
DLF conservatively guided for launch and pre-sales of ₹ 20,000 crore for FY27 (FY26...
We continue to like TVSL on a structural basis, due to its premiumization-led growth,...
Oberoi realty is expected to recoup the lost opportunity in FY27 in terms of...
IHCL’s capital light strategy is a key competitive advantage over other branded hotel companies...
Artemis Medicare Services Ltd (Artemis) is a healthcare venture launched by the promoters of...
We feel most negatives are now behind except concerns around ADD. Lowering conversion cost,...
Premiumisation and D2C play will help AFL revenues/EBIDTA/PAT to grow by 14%/18%/38% respectively.
Market veteran Ashish Kacholia, known for spotting "multibagger" midcaps, has been a major catalyst...